Prediction of lymph node status in stage T1 esophageal squamous cell carcinoma. Efficacy and safety of trastuzumab deruxtecan and nivolumab as third- or later-line treatment for HER2-positive advanced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback